HomeCERO • NASDAQ
CERo Therapeutics Holdings Inc
add
$9.26
2.11%
After Hours:(0.43%)-0.040
$9.22
Closed: Jul 3, 4:27:01 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 5.11M | 12.19% |
Net income | -5.11M | -122.03% |
Net profit margin | — | — |
Earnings per share | -31.80 | — |
EBITDA | -5.03M | -13.34% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 5.20M | 13.29% |
Total assets | 7.99M | -11.72% |
Total liabilities | 8.32M | -36.15% |
Total equity | -329.39K | — |
Shares outstanding | 386.10K | — |
Price to book | -0.89 | — |
Return on assets | -179.84% | — |
Return on capital | -3,555.59% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -5.11M | -122.03% |
Cash from operations | -4.45M | 12.49% |
Cash from investing | — | — |
Cash from financing | 6.32M | -11.67% |
Net change in cash | 1.88M | -9.69% |
Free cash flow | -2.14M | -139.61% |
Previous close
$9.46
Day range
$9.22 - $9.57
Year range
$6.71 - $895.40
Market cap
4.78M USD
Avg Volume
2.25M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2020
Headquarters
Website
Employees
8